CRTO INVESTOR ALERT: Kirby Mcinerney LLP Investigates Potential Claims Involving Criteo S.A.
[CONTACT THE FIRM IF YOU SUFFERED A LOSS ]
What Happened?
On August 5, 2026, Criteo reported its financial results for the second quarter of 2026. The Company reported an 11% year-over-year decline in revenue and a 49% year-over-year decline in net income. Additionally, the Company announced that it was appointing its Chief Strategy Officer, Connor McGogney, as Chief Financial Officer (“CFO”), effective August 10, 2026, succeeding Sarah Glickman who served as CFO since 2020. On this news, Criteo's stock price fell $5.35, or 24%, to close at $17.05 on August 5, 2026.
What Should I Do?
At this stage, no lawsuit has been filed. The investigation is ongoing to determine whether claims may be brought under federal securities laws.
If you purchased or otherwise acquired Criteo securities, have information, or would like to learn more about this investigation, please contact Lauren Molinaro of Kirby McInerney LLP by email at ..., or fill out the contact form below, to discuss your rights or interests with respect to these matters at no cost.
[LEARN MORE ABOUT SECURITIES CLASS ACTIONS]
Kirby McInerney LLP is a New York-based plaintiffs' law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm's efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP's website.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
Kirby McInerney LLP
Lauren Molinaro, Esq.
212-699-1171
...

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.

Comments
No comment